(Q46775423)

25 December 2017

title

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity (English)

1 reference

25 December 2017

0 references

1 reference

1 reference

1 reference

Eirini I Rigopoulou

1

1 reference

25 December 2017

Deepak Suri

2

1 reference

25 December 2017

Shilpa Chokshi

3

1 reference

25 December 2017

Ivana Mullerova

4

1 reference

25 December 2017

Steven Rice

5

1 reference

25 December 2017

Richard S Tedder

6

1 reference

25 December 2017

Roger Williams

7

1 reference

25 December 2017

Nikolai V Naoumov

8

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

25 December 2017

published in

Hepatology

1 reference

25 December 2017

volume

42

1 reference

25 December 2017

page(s)

1028-1036

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

cites work

1 reference

Cellular immune responses to the hepatitis B virus polymerase

21 January 2018

1 reference

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

7 January 2021

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

7 January 2021

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

7 January 2021

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection

1 reference

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

7 January 2021

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

1 reference

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

7 January 2021

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

1 reference

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

7 January 2021

Studies of interleukin-12 in chronic hepatitis B virus infection

1 reference

7 January 2021

Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes

1 reference

7 January 2021

Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12.

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B

1 reference

7 January 2021

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen

1 reference

7 January 2021

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

7 January 2021

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

7 January 2021

A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy

1 reference

7 January 2021

HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.

1 reference

7 January 2021

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

1 reference

7 January 2021

Sterile protection of monkeys against malaria after administration of interleukin-12.

1 reference

7 January 2021

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam

1 reference

7 January 2021

Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients

1 reference

7 January 2021

A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection

1 reference

7 January 2021

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

7 January 2021

Induction of interferon-γ production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation

1 reference

7 January 2021

A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection

1 reference

7 January 2021

Double-blind, randomized controlled trial of interleukin-2 treatment of chronic hepatitis B.

1 reference

7 January 2021

Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes

1 reference

7 January 2021

Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo

1 reference

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

7 January 2021

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

1 reference

7 January 2021

Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection

1 reference

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

7 January 2021

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20888

1 reference

25 December 2017

PubMed ID

16250037

1 reference

25 December 2017